Finance Wales' award-winning portfolio sweeps the board at
MediWales Awards
13 December 2011
Finance
Wales’ portfolio companies won five of six industry awards at the
6th MediWales Awards hosted at Cardiff’s Hilton Hotel. The
prestigious awards recognise excellence in the life sciences
industry.
“Finance Wales is committed to investing in innovative companies
and it’s a real pleasure to see so many of our portfolio companies
winning awards this year. MediWales’ awards are highly regarded in
the life sciences sector,” explained Steve Smith, early stage
investments director at Finance Wales.
Outstanding Growth Award
Biotec Services International was recognised
for its consistent, sustainable and profitable growth, winning
MediWales’ Outstanding Growth Award. Two investment rounds
totalling £900,000 enabled Biotec to target new international
markets, extending its clinical supplies service to Asia, Israel
and the US.
Industry Judge's Award
Calon Cardio Technology received the Industry
Judges’ Award for its potentially world-leading heart failure
treatment. Finance Wales and Longbow Capital invested £1 million in
Calon-Cardio Technology’s low-cost, minimally-invasive blood
pumps.
Find out more about our investment in Calon Cardio Technology.
Industry Export Award
Chromogenex won the Industry Export Award for
the second year running after focusing on a strategy of innovation
and export-led growth. The Llanelli-based company manufactures and
sells laser and light technology systems for cosmetic and medical
treatments. Chromogenex used our £1.2 million investment to target
key strategic and emerging markets, including the USA, South
Africa, Europe and Asia.
Find out more about our investment in Chromogenex.
NHS Partnership with Industry Award
The NHS Partnership with Industry Award went to
Flexicare Medical for its collaboration in
developing and designing the Hall Lock, which prevents patients
from receiving drugs incorrectly. Finance Wales has invested a
total £550,000 over three funding rounds.
Find out more about our investments in Flexicare.
Start-Up Award
Denbighshire-based Microvisk Technologies won
the Start-Up Award for developing its CoagMax blood testing
instrument. Finance Wales first invested in Microvisk in 2009. In
2010, the company raised over £8 million from Finance Wales and a
strong consortium of co-investors.
Links
www.biotec-uk.com
www.caloncardio.com
www.chromogenex.com
www.flexicare.com
www.microvisk.com